(Q38154344)

29 August 2017

Drug discovery and human African trypanosomiasis: a disease less neglected? (English)

1 reference

29 August 2017

0 references

African trypanosomiasis

0 references

(RS)-eflornithine

1 reference

ChEBI release 2020-05-28

1 reference

Lori Ferrins

1

0 references

author name string

Raphaël Rahmani

series ordinal

2

1 reference

PubMed ID

24144414

29 August 2017

Jonathan B Baell

series ordinal

3

1 reference

29 August 2017

1 October 2013

1 reference

Future Medicinal Chemistry

29 August 2017

1 reference

29 August 2017

5

1 reference

29 August 2017

15

1 reference

29 August 2017

1801-1841

1 reference

Human African trypanosomiasis

29 August 2017

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Molecular analysis of archived blood slides reveals an atypical human Trypanosoma infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Developmental cycles and biology of pathogenic trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Potential new drugs for human African trypanosomiasis: some progress at last

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Current situation of African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Fosmidomycin for the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Transporters in African trypanosomes: role in drug action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

A perspective of polyamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

A new molecular approach for cidal vs static antimalarial determination by quantifying mRNA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Application of monoclonal antibodies to measure metabolism of an anti-trypanosomal compound in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Diabetes mellitus following pentamidine-induced hypoglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Evaluating 5-nitrofurans as trypanocidal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Novel naphthoquinone derivatives: synthesis and activity against human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

A crowdsourcing evaluation of the NIH chemical probes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of nitroheterocycles active against African trypanosomes. In vitro screening and preliminary SAR studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Screening the MayBridge Rule of 3 Fragment Library for Compounds That Interact with the Trypanosoma brucei myo-Inositol-3-Phosphate Synthase and/or Show Trypanocidal Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Structure-guided design of a selective BCL-X(L) inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Indatraline: synthesis and effect on the motor activity of Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

[3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complex

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Selective optimization of side activities: the SOSA approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Allicin and derivates are cysteine protease inhibitors with antiparasitic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Identification and Optimization of Inhibitors of Trypanosomal Cysteine Proteases: Cruzain, Rhodesain, and TbCatB

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Novel cruzain inhibitors for the treatment of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Development of antitrypanosomal and antiplasmodial nonpeptidic cysteine protease inhibitors based on N-protected-guanidino-furan and -pyrrole building blocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Anti-trypanosomal activities of DNA topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of Novel Trypanosoma brucei Phosphodiesterase B1 Inhibitors by Virtual Screening against the Unliganded TbrPDEB1 Crystal Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Observations on screening-based research and some concerning trends in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Chemogenomics and parasitology: small molecules and cell-based assays to study infectious processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Whole-organism high-throughput screening against Trypanosoma brucei brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

New bicyclic amines: synthesis and SARs of their action against the causative organisms of malaria and sleeping sickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Antiprotozoal activity of bicyclic diamines with a N-methylpiperazinyl group at the bridgehead atom

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Iotrochamides A and B, antitrypanosomal compounds from the Australian marine sponge Iotrochota sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

In vitro antiprotozoal activity of some xanthones isolated from the roots of Andrographis paniculata.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

7',8'-Dihydroobolactone, a typanocidal alpha-pyrone from the rainforest tree Cryptocarya obovata.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Additional insights on the bastadins: isolation of analogues from the sponge Ianthella cf. reticulata and exploration of the oxime configurations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Natural products active against African trypanosomes: a step towards new drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Hit-to-lead development of the chamigrane endoperoxide merulin A for the treatment of African sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Quantitative structure--antiprotozoal activity relationships of sesquiterpene lactones

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Inhibitory activity of marine sponge-derived natural products against parasitic protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

9β-hydroxyparthenolide esters from Inula montbretiana and their antiprotozoal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Eleganolone, a diterpene from the French marine alga Bifurcaria bifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Antimalarial and antitubercular nostocarboline and eudistomin derivatives: synthesis, in vitro and in vivo biological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Antiparasitic activity of alkaloids from plant species of Papua New Guinea and Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Bromopyrrole alkaloids as lead compounds against protozoan parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

New tetromycin derivatives with anti-trypanosomal and protease inhibitory activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Bioactivities of gossypol, 6-methoxygossypol, and 6,6'-dimethoxygossypol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Marchantin A, a macrocyclic bisbibenzyl ether, isolated from the liverwort Marchantia polymorpha, inhibits protozoal growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

The antiprotozoal activity of methylated flavonoids from Ageratum conyzoides L.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Growing PAINS in academic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

New ligand-based approach for the discovery of antitrypanosomal compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Antitrypanosomal pyridoacridine alkaloids from the Australian ascidian Polysyncraton echinatum

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

8,8-Dialkyldihydroberberines with Potent Antiprotozoal Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Pseudoceratinazole A: a novel bromotyrosine alkaloid from the Australian sponge Pseudoceratina sp

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Larrea tridentata—Absolute configuration of its epoxylignans and investigations on its antiprotozoal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.13.162

21 January 2018

Identifiers

DOI

10.4155/FMC.13.162

1 reference

29 August 2017

1 reference

PubMed ID

24144414